Guideline
2023 American College of Rheumatology (ACR) Guideline for the Screening, Monitoring, and Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Disease
The ACR is developing a new clinical practice guideline for clinicians who care for people with systemic autoimmune rheumatic disease who are at risk for or have been diagnosed with interstitial lung disease (ILD) (final publication of guideline anticipated autumn 2023).
Call for Public Comment
The ACR strongly encourages its members and others to comment on the project plan that will be used in the development of the Guideline for the Screening, Monitoring, and Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Disease by September 29, 2022.